Arcera supports collective action to help prevent antimicrobial resistance
Arcera is joining the global effort to raise awareness of antimicrobial resistance (AMR) during World AMR Awareness Week 2026 (18–24...
Arcera is joining the global effort to raise awareness of antimicrobial resistance (AMR) during World AMR Awareness Week 2026 (18–24...
Arcera Life Sciences announces the publication of its 2025 Sustainability Report, highlighting progress in embedding sustainability across its newly integrated...
Acino, part of Arcera in Ukraine has been named one of the Top 50 best employers in Ukraine and ranked...
Acino, part of Arcera, has obtained a qualification release for its prescription antipsychotic medicine Ariprazol® (aripiprazole) in the European Union,...
Acino South Africa has been certified as a Top Employer by the independent Top Employers Institute for the fifth consecutive...
The 2024 report outlines Arcera’s current ESG initiatives and long-term ambitions, including a firm commitment to achieving full carbon neutrality...
We are thrilled to announce that Acino, part of Arcera, has been certified as one of the Best Place to...
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.